Abstract

Persons with inflammatory bowel disease (IBD) make up more than 0.75% of the Canadian population in 2021. Early in the COVID-19 pandemic, individuals with IBD, particularly those on immunosuppressive therapies, were concerned that their health status may place them at higher risk of contracting COVID-19 or experiencing more severe disease course if infected with SARS-CoV-2. In response, Crohn’s and Colitis Canada developed the COVID-19 and IBD Taskforce in March 2020 to rapidly synthesize the evolving knowledge of COVID-19 as relevant to Canadians with IBD. The Taskforce communicated expert information directly to the Canadian IBD community through online tools and a webinar series. In order to understand the full impact of COVID-19 on the IBD community, Crohn’s and Colitis Canada commissioned a policy report that was informed through a systematic literature review and synthesized across working groups along the following domains: Epidemiology, Children and Expectant Mothers with IBD, Seniors with IBD, Mental Health, Risk Factors and Medications, Vaccines, and Healthcare Delivery during the Pandemic and the Future Model of IBD Care. This report from Canadian physicians, researchers, and IBD community representatives highlights the physical, mental, and health systems impact of COVID-19 on the entire spectrum of the IBD community, including children, adolescents, adults, seniors, and pregnant people with IBD. This executive summary provides an overview of the crucial information from each of the chapters of the policy report, supplemented with additional information made available through Crohn’s and Colitis Canada’s webinar-based knowledge translation platform.

Details

Title
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
Author
Kuenzig, M Ellen 1 ; Windsor, Joseph W 2 ; Barrett, Lisa 3 ; Bernstein, Charles N 4 ; Bitton, Alain 5 ; Carroll, Matthew W 6 ; Chauhan, Usha 7 ; Coward, Stephanie 8 ; Fowler, Sharyle 9 ; Jean-Eric Ghia 10 ; Geist, Rose 11 ; Gibson, Deanna L 12 ; Graff, Lesley A 13 ; Griffiths, Anne M 14 ; Huang, James Guoxian 15 ; Jones, Jennifer L 3 ; Khanna, Reena 16 ; Lakatos, Peter L 17 ; Lee, Kate 18 ; Mack, David R 19 ; Marshall, John K 7 ; Mukhtar, Mariam S 20 ; Murthy, Sanjay K 21 ; Nguyen, Geoffrey C 22 ; Panaccione, Remo 23 ; Seow, Cynthia H 8 ; Singh, Harminder 4 ; Tandon, Parul 24 ; Targownik, Laura E 24 ; Zelinsky, Sandra 2 ; Benchimol, Eric I 14 ; Kaplan, Gilaad G 8 

1  SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada 
2  Department of Medicine, University of Calgary, Calgary, Alberta, Canada 
3  Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada 
4  Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada 
5  Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada 
6  Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada 
7  Hamilton Health Science, Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 
8  Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Departments of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada 
9  Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada 
10  Department of Immunology and Internal Medicine section of Gastroenterology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba and University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, Manitoba, Canada 
11  Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada 
12  Department of Biology, Faculty of Science; Department of Medicine, Faculty of Medicine, The University of British Columbia, Okanagan campus, Kelowna, British Columbia, Canada 
13  University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada; Department of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada 
14  SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada; ICES, Toronto, Ontario, Canada; Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 
15  SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada 
16  London Health Sciences Centre-University Campus, Western University, London, Ontario, Canada 
17  Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; 1st Department of Medicine, Semmelweis University, Budapest, Hungary 
18  Crohn’s and Colitis Canada, Toronto, Ontario, Canada 
19  CHEO Inflammatory Bowel Disease Centre and Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada 
20  Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia 
21  The Ottawa Hospital IBD Centre, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada 
22  Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada 
23  Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada 
24  Division of Gastroenterology and Hepatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada 
Pages
S1-S9
Publication year
2021
Publication date
Dec 2021
Publisher
Oxford University Press
ISSN
25152084
e-ISSN
25152092
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1093/jcag/gwab027
ProQuest document ID
3168647101
Copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.